Search research articles
Contact Us
Filters
Showing results (81-90 of 110) with videos related to
Page
of 11
Sort By:
Journal of the American College of Cardiology
|
October 22, 2008
The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention
Eugenio Stabile, Wail Nammas, Luigi Salemme, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
July 9, 2014
Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome
Jussi Sia, Wail Nammas, Matti Niemelä, et al.
Annals of Medicine
|
May 7, 2015
Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study
Jussi Jaakkola, Juha E K Hartikainen, Tuomas Kiviniemi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 10, 2014
Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention
Tuomas Kiviniemi, Marja Puurunen, Axel Schlitt, et al.
The Journal of Invasive Cardiology
|
March 6, 2012
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial
Petri O Tuomainen, Antti Ylitalo, Matti Niemelä, et al.
The International Journal of Cardiovascular Imaging
|
September 3, 2013
Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
Pasi Karjalainen, Tuomas O Kiviniemi, Tuomas Lehtinen, et al.
International Journal of Cardiology
|
January 8, 2018
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
Wail Nammas, Tuomas Kiviniemi, Axel Schlitt, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
December 16, 2014
Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial
Pasi P Karjalainen, Ville Varho, Wail Nammas, et al.
International Journal of Cardiology
|
August 7, 2016
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial
Pasi P Karjalainen, Wail Nammas, Antti Ylitalo, et al.
International Journal of Cardiology
|
December 11, 2012
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial
Petri O Tuomainen, Antti Ylitalo, Matti Niemelä, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 110) with videos related to
Sort By:
Page
of 11
Journal of the American College of Cardiology
|
October 22, 2008
The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention
Eugenio Stabile, Wail Nammas, Luigi Salemme, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
July 9, 2014
Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome
Jussi Sia, Wail Nammas, Matti Niemelä, et al.
Annals of Medicine
|
May 7, 2015
Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study
Jussi Jaakkola, Juha E K Hartikainen, Tuomas Kiviniemi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 10, 2014
Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention
Tuomas Kiviniemi, Marja Puurunen, Axel Schlitt, et al.
The Journal of Invasive Cardiology
|
March 6, 2012
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial
Petri O Tuomainen, Antti Ylitalo, Matti Niemelä, et al.
The International Journal of Cardiovascular Imaging
|
September 3, 2013
Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
Pasi Karjalainen, Tuomas O Kiviniemi, Tuomas Lehtinen, et al.
International Journal of Cardiology
|
January 8, 2018
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
Wail Nammas, Tuomas Kiviniemi, Axel Schlitt, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
December 16, 2014
Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial
Pasi P Karjalainen, Ville Varho, Wail Nammas, et al.
International Journal of Cardiology
|
August 7, 2016
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial
Pasi P Karjalainen, Wail Nammas, Antti Ylitalo, et al.
International Journal of Cardiology
|
December 11, 2012
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial
Petri O Tuomainen, Antti Ylitalo, Matti Niemelä, et al.
Page
of 11